I applaud this subcommittee for its recent action to advance a number of bills related to drug pricing.
David Schweikert: “I applaud this subcommittee for its recent action to advance a number of bills related to drug pricing.”
Editor's note · Context
David Schweikert commends the subcommittee for addressing drug pricing issues.
Share
More from David Schweikert
I promise you at least this one. I think I have the half an hour. I am going to try not to use all of it, and I will try to slow down some of the speaking. Madam Speaker, I had a couple of odds and ends and then some basic optimism on one…
I have a number of things to go over. Mr. Speaker, do you remember over the last few years the number of discussions we would have at home, saying drain the swamp? What was the term, swamp critters? We have been collecting a number of…
to my appropriator friend, this is the game that we play, and this is where we talk past each other. Can I give an actual example? Clean coal technology, appropriated August 18, 2015; unobligated balance, $2 million. In the scale we deal…





